Related Experiment Video
Updated: Jul 14, 2025
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.0K
Tinnitus and treatment-resistant depression.
Berthold Langguth1, An-Suey Shiao2, Jen-Tsung Lai3
1Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Progress in Brain Research
|October 8, 2023
Summary
Tinnitus is the perception of phantom sound, with Tinnitus Disorder impacting 2-3% of people. Addressing comorbidities like depression is crucial for managing tinnitus distress, as causal treatments are unavailable.
Area of Science:
- Neuroscience
- Otolaryngology
- Psychiatry
Background:
- Tinnitus is the perception of phantom sound, affecting a significant portion of the population.
- A distinction is made between tinnitus (auditory component) and Tinnitus Disorder (auditory component plus suffering).
- High tinnitus burden is linked to comorbidities, notably depression.
Conclusions:
- Identifying and treating comorbidities, particularly depression and TRD, is vital for reducing tinnitus-related suffering.
- Understanding the link between tinnitus and depression is essential for comprehensive patient care.
- Further research into the relationship between tinnitus and treatment-resistant depression is warranted.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
260
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
260
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
418
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
418
01:18Depression: Overview
263
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
263
01:05Long-term Depression
30.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.9K
01:30Electroconvulsive Therapy
50
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
50
01:26Psychosis: Goals of Pharmacotherapy
150
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
150